Many parts of the world have experienced a period when infection status testing became reliable and meaningful. However, the expected success of the much awaited vaccines, now about to be approved, will inevitably create testing uncertainty, provide greater opportunities for false claims and create new costs for liability insurers. Regulators should consider making a requirement for double testing. This would not only protect citizens from unwarranted restrictions of personal freedom and associated costs but would create reasonable certainty of facts at common law.
A Limitation period of three years will create ample opportunities for claims supported by doubtful evidence.
